Is BNGO or ILMN more undervalued in 2026?

CirclFi compares Bionano Genomics, Inc. (BNGO) and Illumina, Inc. (ILMN) using 13 institutional-grade valuation models. BNGO has a Quality of Company score of 6.0/10 while ILMN scores 8.5/10.

Which is a better buy — BNGO or ILMN?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do BNGO and ILMN valuations compare?

BNGO at $1.24 and ILMN at $162.96 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

BNGO vs ILMN Valuation Comparison 2026 — Intrinsic Value Analysis

BNGO

Laboratory Analytical Instruments

Bionano Genomics, Inc.

Quality

6.0

out of 10

Value Trap

LOW

Price

$1.24

Last close

Models

10/13

Active

ILMN

Laboratory Analytical Instruments

Illumina, Inc.

Quality

8.5

out of 10

Value Trap

SAFE

Price

$162.96

Last close

Models

13/13

Active

Model-by-Model Comparison

Model	Type	BNGO Fair Value	BNGO Upside	ILMN Fair Value	ILMN Upside
Bayesian DCF	Intrinsic	$0.25	-79.6%	$53.35	-67.3%
Earnings Power Value	Intrinsic	—	—	$131.24	-19.5%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.50	-59.6%	$87.32	-46.4%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for BNGO vs ILMN — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

BNGO vs ILMN — Which Stock Is More Undervalued?

ILMN scores higher with a 8.5/10 quality rating vs BNGO's 6.0/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Bionano Genomics, Inc. (BNGO) and Illumina, Inc. (ILMN) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

BNGO currently trades at $1.24 with a QOC of 6.0/10, while ILMN trades at $162.96 with a QOC of 8.5/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).